Search

Conan Li

from Orlando, FL
Get Report
Related to:
Laura EliLi ConanQin Li, 45
Connected to:
Ai Q Li, 64Ai H Li, 81Aida Li, 67Aijun Li, 65Aiwen Q Li, 56Aiyan Li, 61Alan Li, 80Alice Li, 46Alida Li, 59Alisha Li, 31

Conan Li Phones & Addresses

  • Orlando, FL

Work

Company: Health freedom network inc. May 2009 Position: President

Education

Degree: MBA with Distinction School / High School: Cornell University - S.C. Johnson Graduate School of Management 1999 to 2001 Specialities: Business Administration

Skills

Medical Devices • Fda • R&D • Validation • Biotechnology • Product Development • Clinical Trials • Lifesciences • Life Sciences • Commercialization • Design Control • Laboratory • Hardware Diagnostics • Clinical Development • Cross Functional Team Leadership • Pharmaceutical Industry • Genomics • Infectious Diseases • Assay Development • Start Ups • Healthcare • Technology Transfer • Product Launch • Regulatory Affairs • Clinical Research • Cancer • Gmp • Glp • 21 Cfr Part 11 • Iso 13485 • Quality System • Chemistry • Capa • Research and Development • Biomedical Engineering • Medical Diagnostics • U.s. Food and Drug Administration • Diagnostics

Languages

Mandarin

Industries

Biotechnology

Resumes

Resumes

Conan Li Photo 1

Medical Science Director

View page
Location:
108 Shady Lake Dr, Sewickley, PA 15143
Industry:
Biotechnology
Work:
Health Freedom Network Inc. since May 2009
President
Nexus Dx - Piscataway NJ Sep 2009 - Jul 2011
Executive VP of R&D
Cholestech 2007 - Apr 2009
VP of R&D
Inverness Medical Innov. Mar 2008 - Jan 2009
General Manager at HemoSense
HemoSense Inc. Jan 2007 - Mar 2008
Vice President of R&D and Clinical Affairs
Education:
Cornell University - S.C. Johnson Graduate School of Management 1999 - 2001
MBA with Distinction, Business Administration Harvard University
PhD, Biophysics Massachusetts Institute of Technology
SB, Physics
Skills:
Medical Devices
Fda
R&D
Validation
Biotechnology
Product Development
Clinical Trials
Lifesciences
Life Sciences
Commercialization
Design Control
Laboratory
Hardware Diagnostics
Clinical Development
Cross Functional Team Leadership
Pharmaceutical Industry
Genomics
Infectious Diseases
Assay Development
Start Ups
Healthcare
Technology Transfer
Product Launch
Regulatory Affairs
Clinical Research
Cancer
Gmp
Glp
21 Cfr Part 11
Iso 13485
Quality System
Chemistry
Capa
Research and Development
Biomedical Engineering
Medical Diagnostics
U.s. Food and Drug Administration
Diagnostics
Languages:
Mandarin

Publications

Us Patents

Artificial Immune System: Methods For Making And Use

View page
US Patent:
8288159, Oct 16, 2012
Filed:
Mar 17, 2010
Appl. No.:
12/725698
Inventors:
William L Warren - Orlando FL, US
Heather Fahlenkamp - Cleveland OK, US
Russell Higbee - Orlando FL, US
Anatoly Kachurin - Orlando FL, US
Conan Li - Los Altos CA, US
Mike Nguyen - Orlando FL, US
Robert Parkhill - Orlando FL, US
Darrell J. Irvine - Arlington MA, US
Gwendalyn J. Randolph - New York NY, US
Bruce Torbett - Encinitas CA, US
Assignee:
Sanofi Pasteur Vaxdesign Corp. et al. - Orlando FL
International Classification:
C12N 5/06
C12N 5/02
US Classification:
435326, 435375, 435377
Abstract:
The present invention relates to methods of constructing an integrated artificial immune system that comprises appropriate in vitro cellular and tissue constructs or their equivalents to mimic the normal tissues that interact with vaccines in mammals. The artificial immune system can be used to test the efficacy of vaccine candidates in vitro and thus, is useful to accelerate vaccine development and testing drug and chemical interaction with the immune system.

Artificial Immune System: Methods For Making And Use

View page
US Patent:
20050282148, Dec 22, 2005
Filed:
Apr 28, 2005
Appl. No.:
11/116234
Inventors:
William Warren - Orlando FL, US
Heather Fahlenkamp - Oviedo FL, US
Russell Higbee - Orlando FL, US
Anatoly Kachurin - Orlando FL, US
Conan Li - Orlando FL, US
Mike Nguyen - Orlando FL, US
Robert Parkhill - Orlando FL, US
Darrell Irvine - Arlington MA, US
Gwendalyn Randolph - New york NY, US
Nir Hacohen - Brookline MA, US
Bruce Torbett - Encinitas CA, US
International Classification:
C12Q001/00
C12N005/08
US Classification:
435004000, 435366000, 435289100
Abstract:
The present invention relates to methods of constructing an integrated artificial immune system that comprises appropriate in vitro cellular and tissue constructs or their equivalents to mimic the normal tissues that interact with vaccines in mammals. The artificial immune system can be used to test the efficacy of vaccine candidates in vitro and thus, is useful to accelerate vaccine development and testing drug and chemical interaction with the immune system.

Porous Membrane Device That Promotes The Differentiation Of Monocytes Into Dendritic Cells

View page
US Patent:
20070178076, Aug 2, 2007
Filed:
Dec 21, 2006
Appl. No.:
11/642926
Inventors:
Donald Drake - Orlando FL, US
David Moe - Orlando FL, US
Conan Li - Los Altos CA, US
Heather Fahlenkamp - Cleveland OK, US
Russell Higbee - Orlando FL, US
Robert Parkhill - Orlando FL, US
William Warren - Orlando FL, US
International Classification:
A61K 48/00
C12M 3/00
C12N 5/08
US Classification:
424093210, 435372000, 435285100
Abstract:
Dendritic cells (DCs) for research and clinical applications are typically derived from purified blood monocytes that are cultured in a cocktail of cytokines for a week or more. Because it has been suggested that these cytokine-derived DCs may be deficient in some important immunological functions and might not accurately represent antigen-presenting cell (APC) populations found under physiologic conditions, there is a need for methods that allow the generation of DCs in a more physiologically relevant manner. The present invention comprises a simple and reliable technique for generating large numbers of highly purified DCs, based on a single migration of blood monocytes through endothelial cells that are cultured in, for example, a Transwell device. The resultant APCs, harvested from the lower Transwell chamber, resemble other in vitro-generated DC populations in their expression of major histocompatibility (MHC) and costimulatory molecules, ability to phagocytose foreign antigens, and capacity to trigger antigen-specific T cell responses.

Porous Membrane Device That Promotes The Differentiation Of Monocytes Into Dendritic Cells

View page
US Patent:
20100105135, Apr 29, 2010
Filed:
Oct 30, 2009
Appl. No.:
12/609060
Inventors:
Donald DRAKE, III - Orlando FL, US
David MOE - Orlando FL, US
Conan LI - Los Altos CA, US
Heather FAHLENKAMP - Cleveland OK, US
Russell HIGBEE - Orlando FL, US
Robert PARKHILL - Orlando FL, US
William L. WARREN - Orlando FL, US
Assignee:
VaxDesign Corp. - Orlando FL
International Classification:
C12N 5/0784
US Classification:
435372
Abstract:
Dendritic cells (DCs) for research and clinical applications are typically derived from purified blood monocytes that are cultured in a cocktail of cytokines for a week or more. Because it has been suggested that these cytokine-derived DCs may be deficient in some important immunological functions and might not accurately represent antigen-presenting cell (APC) populations found under physiologic conditions, there is a need for methods that allow the generation of DCs in a more physiologically relevant manner. The present invention comprises a simple and reliable technique for generating large numbers of highly purified DCs, based on a single migration of blood monocytes through endothelial cells that are cultured in, for example, a Transwell device. The resultant APCs, harvested from the lower Transwell chamber, resemble other in vitro-generated DC populations in their expression of major histocompatibility (MHC) and costimulatory molecules, ability to phagocytose foreign antigens, and capacity to trigger antigen-specific T cell responses.

Artificial Immune System: Methods Of Use

View page
US Patent:
20130078656, Mar 28, 2013
Filed:
Sep 10, 2012
Appl. No.:
13/608579
Inventors:
William L. WARREN - Orlando FL, US
Heather FAHLENKAMP - Cleveland OK, US
Russell HIGBEE - Orlando FL, US
Anatoly KACHURIN - Orlando FL, US
Conan LI - Los Altos CA, US
Mike NGUYEN - Orlando FL, US
Robert PARKHILL - Orlando FL, US
Darrell J. IRVINE - Arlington MA, US
Gwendalyn J. RANDOLPH - New York NY, US
Nir HACOHEN - Brookline MA, US
Bruce TORBETT - Encinitas CA, US
Assignee:
SANOFI PASTEUR VAXDESIGN CORPORATION - Orlando FL
THE WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH - CAMBRIDGE MA
MASSACHUSETTS INSTITUTE OF TECHNOLOGY - CAMBRIDGE MA
THE SCRIPPS RESEARCH INSTITUTE - LA JOLLA CA
International Classification:
C12N 5/071
US Classification:
435 794, 435 29, 435 792
Abstract:
The present invention relates to methods of constructing an integrated artificial immune system that comprises appropriate in vitro cellular and tissue constructs or their equivalents to mimic the normal tissues that interact with vaccines in mammals. The artificial immune system can be used to test the efficacy of vaccine candidates in vitro and thus, is useful to accelerate vaccine development and testing drug and chemical interaction with the immune system.
Control profile
Conan Li from Orlando, FL Get Report